157 related articles for article (PubMed ID: 29284501)
1. Nucleoli cytomorphology in cutaneous melanoma cells - a new prognostic approach to an old concept.
Donizy P; Biecek P; Halon A; Maciejczyk A; Matkowski R
Diagn Pathol; 2017 Dec; 12(1):88. PubMed ID: 29284501
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Nucleoli Cytomorphology Assessment in Patients With Uveal Melanoma.
Berus T; Markiewicz A; Biecek P; Orłowska-Heitzman J; Hałoń A; Romanowska-Dixon B; Donizy P
Anticancer Res; 2020 Jun; 40(6):3505-3512. PubMed ID: 32487651
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
4. Nuclear pseudoinclusions in melanoma cells: prognostic fact or artifact? The possible role of Golgi phosphoprotein 3 overexpression in nuclear pseudoinclusions generation.
Donizy P; Kaczorowski M; Biecek P; Halon A; Matkowski R
Pathol Int; 2018 Feb; 68(2):117-122. PubMed ID: 29377340
[TBL] [Abstract][Full Text] [Related]
5. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis.
Donizy P; Kaczorowski M; Leskiewicz M; Zietek M; Pieniazek M; Kozyra C; Halon A; Matkowski R
Oncol Rep; 2014 Dec; 32(6):2735-43. PubMed ID: 25310673
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of immunohistochemical epithelial-mesenchymal transition markers in skin melanoma patients.
Pieniazek M; Donizy P; Halon A; Leskiewicz M; Matkowski R
Biomark Med; 2016 Sep; 10(9):975-85. PubMed ID: 27586584
[TBL] [Abstract][Full Text] [Related]
7. Golgi-Related Proteins GOLPH2 (GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in Cutaneous Melanoma: Patterns of Expression and Prognostic Significance.
Donizy P; Kaczorowski M; Biecek P; Halon A; Szkudlarek T; Matkowski R
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27706081
[TBL] [Abstract][Full Text] [Related]
8. Uveal melanoma: mean of the longest nucleoli measured on silver-stained sections.
Moshari A; McLean IW
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1160-3. PubMed ID: 11328722
[TBL] [Abstract][Full Text] [Related]
9. PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma-A Clinical and an In Vitro Study.
Kupczyk P; Simiczyjew A; Marczuk J; Dratkiewicz E; Beberok A; Rok J; Pieniazek M; Biecek P; Nevozhay D; Slowikowski B; Chodaczek G; Wrzesniok D; Nowak D; Donizy P
Cells; 2021 Jan; 10(2):. PubMed ID: 33572647
[TBL] [Abstract][Full Text] [Related]
10. Lymphangioinvasion in routine H&E staining is strongly associated with poor clinical outcome in lymph node-negative cutaneous melanoma patients.
Donizy P; Kaczorowski M; Halon A; Leskiewicz M; Matkowski R
Folia Histochem Cytobiol; 2016; 54(3):126-133. PubMed ID: 27654015
[TBL] [Abstract][Full Text] [Related]
11. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
[TBL] [Abstract][Full Text] [Related]
12. Paucity of tumor-infiltrating lymphocytes is an unfavorable prognosticator and predicts lymph node metastases in cutaneous melanoma patients.
Donizy P; Kaczorowski M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Anticancer Res; 2015 Jan; 35(1):351-8. PubMed ID: 25550571
[TBL] [Abstract][Full Text] [Related]
13. Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationship with clinicopathological characteristics and prognosis.
Eiró N; Ovies C; Fernandez-Garcia B; Álvarez-Cuesta CC; González L; González LO; Vizoso FJ
Arch Dermatol Res; 2013 Jan; 305(1):59-67. PubMed ID: 23179584
[TBL] [Abstract][Full Text] [Related]
14. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS
Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma.
Poukka M; Bykachev A; Siiskonen H; Tyynelä-Korhonen K; Auvinen P; Pasonen-Seppänen S; Sironen R
BMC Cancer; 2016 May; 16():313. PubMed ID: 27184066
[TBL] [Abstract][Full Text] [Related]
16. SMAD7 is a novel independent predictor of survival in patients with cutaneous melanoma.
Kaczorowski M; Biecek P; Donizy P; Pieniazek M; Matkowski R; Halon A
Transl Res; 2019 Feb; 204():72-81. PubMed ID: 30342000
[TBL] [Abstract][Full Text] [Related]
17. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
[TBL] [Abstract][Full Text] [Related]
18. Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma.
Ladstein RG; Bachmann IM; Straume O; Akslen LA
J Invest Dermatol; 2012 Apr; 132(4):1247-52. PubMed ID: 22297638
[TBL] [Abstract][Full Text] [Related]
19. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors.
Al-Jamal RT; Kivelä T
Curr Eye Res; 2006 Jan; 31(1):57-67. PubMed ID: 16421020
[TBL] [Abstract][Full Text] [Related]
20. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
